Richard R Copp, Jr

Title: Richard R Copp, Jr: Innovator in Pharmaceutical Chemistry

Introduction

Richard R Copp, Jr is a notable inventor based in Kenosha, WI (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes and formulations. With a total of 2 patents, his work has had a meaningful impact on the industry.

Latest Patents

Richard's latest patents include the "Synthesis and isolation of N-(aryl or heteroaryl)-alkyl-N-hydroxyurea." This invention provides a simple, one-step process for preparing N-(aryl or heteroaryl)-hydroxyurea by reacting the corresponding alcohol, ester, or ether with hydroxyurea and acid. This reaction is particularly useful for preparing a benzo[b]thienyl substituted N-hydroxyurea. The second patent is for a "Process for N-desmethylating erythromycins and derivatives thereof." This patent discloses an improved and efficient process for N-desmethylating the 3'-amino nitrogen of erythromycins and converting them into 3'-N-substituted derivatives of 8,9-anhydro-erythromycin 6,9-hemiketals.

Career Highlights

Richard R Copp, Jr is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions that address complex pharmaceutical challenges.

Collaborations

Richard has collaborated with notable coworkers such as John E Hengeveld and Elise H Leese. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Richard R Copp, Jr is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative patents and collaborations reflect his commitment to advancing the field.